Graft Failure: Etiology, Recognition, and Treatment

Transplantation of the Liver

Volumn , Issue , 2005, Pages 915-928

  Nissen, Nicholas N ^a,b   Colquhoun, Steven D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67650085936     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0118-2.50066-5     Document Type: Chapter

References (79)

1. RW Busuttil and K Tanaka (2003) The utility of marginal donors in liver transplantation. Liver Transpl 9 651-663.
2. CM Lo, CL Liu and ST Fan (2003) Portal hyperperfusion injury as the cause of primary nonfunction in a small-for-size liver graft—successful treatment with splenic artery ligation. Liver Transpl 9 626-628.
3. United Network of Organ Sharing. www.UNOS.org 2003.
4. RW Busuttil, A Shaked, JM Millis, et al. (1994) One thousand liver transplants. The lessons learned. Ann Surg 219 490-497. discussion 498–499
5. Anselmo DM, Baquerizo A, Geerarghese S, et al: Liver transplantation at Dumont-UCLA Transplant Center: An experience with over 3,000 cases. Clin Transpl 179–186, 2001.
6. A Jain, J Reyes, R Kashyap, et al. (2000) Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 232 490-500.
7. PD Greig, GM Woolf, SB Sinclair, et al. (1989) Treatment of primary liver graft nonfunction with prostaglandin E1. Transplantation 48 447-453.
8. AM D'Alessandro, M Kalayoglu, HW Sollinger, et al. (1991) The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 51 157-163.
9. SM Strasberg, TK Howard, EP Molmenti and M Hertl (1994) Selecting the donor liver: Risk factors for poor function after orthotopic liver transplantation. Hepatology 20 829-838.
10. RJ Ploeg, AM D'Alessandro, SJ Knechtle, et al. (1993) Risk factors for primary dysfunction after liver transplantation—a multivariate analysis. Transplantation 55 807-813.
11. S Hwang, SG Lee, YJ Lee, et al. (2002) A case of primary non-function following adult-to-adult living donor liver transplantation. Hepatogastroenterology 49 1412-1414.
12. E Mor, GB Klintmalm, TA Gonwa, et al. (1992) The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation 53 383-386.
13. HR Rosen, P Martin, J Goss, et al. (1998) Significance of early aminotransferase elevation after liver transplantation. Transplantation 65 68-72.
14. G Novelli, M Rossi, R Pretagostini, et al. (2002) MARS (Molecular Adsorbent Recirculating System): Experience in 34 cases of acute liver failure. Liver 22(Suppl 2), 43-47.
15. AK Mandal, KE King, SL Humphreys, et al. (2000) Plasmapheresis: An effective therapy for primary allograft nonfunction after liver transplantation. Transplantation 70 216-220.
16. L Grande, A Rimola, JC Garcia-Valdecasas, et al. (1992) Recovery of liver graft after initial poor function. Transplantation 53 228-230.
17. R Rull, O Vidal, D Momblan, et al. (2003) Evaluation of potential liver donors: Limits imposed by donor variables in liver transplantation. Liver Transpl 9 389-393.
18. L Makowka, RD Gordon, S Todo, et al. (1987) Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc 19 2378-2382.
19. FJ Fernandez-Merino, J Nuno-Garza, P Lopez-Hervas, et al. (2003) Impact of donor, recipient, and graft features on the development of primary dysfunction in liver transplants. Transplant Proc 35 1793-1794.
20. F Zamboni, A Franchello, E David, et al. (2001) Effect of macrovesicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation. Clin Transplant 15 53-57.
21. J Briceno, T Marchal, J Padillo, et al. (2002) Influence of marginal donors on liver preservation injury. Transplantation 74 522-526.
22. H Popper (1985) Relations between liver and aging. Semin Liver Dis 5 221-227.
23. HA Wynne, LH Cope, E Mutch, et al. (1989) The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 9 297-301.
24. J Busquets, X Xiol, J Figueras, et al. (2001) The impact of donor age on liver transplantation: Influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation 71 1765-1771.
25. G Tisone, TM Manzia, S Zazza, et al. (2004) Marginal donors in liver transplantation. Transplant Proc 36 525-526.
26. H Yersiz, A Shaked, K Olthoff, et al. (1995) Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 60 790-794.
27. GL Grazi, M Cescon, M Ravaioli, et al. (2001) A revised consideration on the use of very aged donors for liver transplantation. Am J Transplant 1 61-68.
28. M Deschenes, C Forbes, J Tchervenkov, et al. (1999) Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation. Liver Transpl Surg 5 357-361.
29. N Cuende, L Grande, R Sanjuan and V Cuervas-Mons (2002) Liver transplant with organs from elderly donors: Spanish experience with more than 300 liver donors over 70 years of age. Transplantation 73 1360.
30. M Cescon, GL Grazi, G Ercolani, et al. (2003) Long-term survival of recipients of liver grafts from donors older than 80 years: Is it achievable? Liver Transpl 9 1174-1180.
31. 2002 Annual Report. The U.S. Organ Procurement and Transplantation Network and The Scientific Registry of Transplant Recipients Transplant Data 1992–2001, 2002.
32. CJ Imber, DS St Peter, A Handa and RJ Friend (2002) Hepatic steatosis and its relationship to transplantation. Liver Transpl 8 415-423.
33. M Selzner and PA Clavien (2001) Fatty liver in liver transplantation and surgery. Semin Liver Dis 21 105-113.
34. R Adam, M Reynes, M Johann, et al. (1991) The outcome of steatotic grafts in liver transplantation. Transplant Proc 23 1538-1540.
35. M Hilden, P Christofferson, E Juhl and JB Dalgaard (1977) Liver histology in a ‘normal’ population—examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol 12 593-597.
36. MA Garcia Urena, F Colina Ruiz-Delgado, E Moreno Gonzalez, et al. (1998) Hepatic steatosis in liver transplant donors: Common feature of donor population? World J Surg 22 837-844.
37. S Todo, AJ Demetris, L Makowka, et al. (1989) Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 47 903-905.
38. HY Yoo, E Molmenti and PJ Thuluvath (2003) The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation. Liver Transpl 9 72-78.
39. Y Soejima, M Shimada, T Suehiro, et al. (2003) Use of steatotic graft in living-donor liver transplantation. Transplantation 76 344-348.
40. CK Ryan, LA Johnson, BI Germin and A Marcos (2002) One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 8 1114-1122.
41. TM Fishbein, MI Fiel, S Emre, et al. (1997) Use of livers with microvesicular fat safely expands the donor pool. Transplantation 64 248-251.
42. PA Clavien and M Selzner (2002) Hepatic steatosis and transplantation. Liver Transpl 8 980.
43. T Fukumori, N Ohkohchi, S Tsukamoto and S Satomi (1999) The mechanism of injury in a steatotic liver graft during cold preservation. Transplantation 67 195-200.
44. E Ardite, C Ramos, A Rimola, et al. (1999) Hepatocellular oxidative stress and initial graft injury in human liver transplantation. J Hepatol 31 921-927.
45. JC Emond, JF Renz, LD Ferrell, et al. (1996) Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg 224 544-552. discussion 552–554
46. CM Lo, ST Fan, CL Liu, et al. (1999) Minimum graft size for successful living donor liver transplantation. Transplantation 68 1112-1116.
47. M Ben-Haim, S Emre, TM Fishbein, et al. (2001) Critical graft size in adult-to-adult living donor liver transplantation: Impact of the recipient's disease. Liver Transpl 7 948-953.
48. K Urata, S Kawasaki, H Matsunami, et al. (1995) Calculation of child and adult standard liver volume for liver transplantation. Hepatology 21 1317-1321.
49. T Kiuchi, M Kasahara, K Uryuhara, et al. (1999) Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 67 321-327.
50. T Kiuchi, K Tanaka, T Ito, et al. (2003) Small-for-size graft in living donor liver transplantation: How far should we go? Liver Transpl 9(9), S29-S35.
51. DG Farmer, H Yersiz, RM Ghobrial, et al. (2001) Early graft function after pediatric liver transplantation: Comparison between in situ split liver grafts and living-related liver grafts. Transplantation 72 1795-1802.
52. R Troisi and B de Hemptinne (2003) Clinical relevance of adapting portal vein flow in living donor liver transplantation in adult patients. Liver Transpl 9(9), S36-S41.
53. T Ito, T Kiuchi, H Yamamoto, et al. (2003) Changes in portal venous pressure in the early phase after living-donor liver transplantation: Pathogenesis and clinical implications. Transplantation 75 1313-1317.
54. K Man, CM Lo, IO Ng, et al. (2001) Liver transplantation in rats using small-for-size grafts: A study of hemodynamic and morphological changes. Arch Surg 136 280-285.
55. K Man, CM Lo, T. Lee Tk, et al. (2003) Intragraft gene expression profiles by cDNA microarray in small size liver grafts. Liver Transpl 9 425-432.
56. TE Starzl, AJ Demetris and D Van Theil (1989) Liver transplantation. N Engl J Med 321 1014-1022.
57. J Figueras, J Busquets, L Grande, et al. (1996) The deleterious effect of donor high plasma sodium and extended preservation in liver transplantation. A multivariate analysis. Transplantation 61 410-413.
58. E Totsuka, F Dodson, A Urakami, et al. (1999) Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: Effect of correction of donor hypernatremia. Liver Transpl Surg 5 421-428.
59. VK Rustgi, G Marino, MT Halpern, et al. (2002) Role of gender and race mismatch and graft failure in patients undergoing liver transplantation. Liver Transpl 8 514-518.
60. S Okamoto, CO Corso, D Nolte, et al. (1998) Impact of brain death on hormonal homeostasis and hepatic microcirculation of transplant organ donors. Transpl Int 11(Suppl 1), S404-S407.
61. T Komokata, S Nishida, S Ganz, et al. (2003) The impact of donor chemical overdose on the outcome of liver transplantation. Transplantation 76 705-708.
62. JL Wisecaver, SJ Radio, BW Shaw Jr, et al. (1994) Intrahepatic arteriopathy associated with primary nonfunction of liver allografts. Hum Pathol 25 960-963.
63. AM D'Alessandro, M Kalayoglu, HW Sollinger, et al. (1991) Current status of organ preservation with University of Wisconsin solution. Arch Pathol Lab Med 115 306-310.
64. H Furukawa, S Todo, O Imventarza, et al. (1991) Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation 51 1000-1004.
65. PL Abt, NM Desai, MD Crawford, et al. (2004) Survival following liver transplantation from non-heart-beating donors. Ann Surg 239 87-92.
66. KS Suh, SB Kim, SH Chang, et al. (2002) Significance of positive cytotoxic cross-match in adult-to-adult living donor liver transplantation using small graft volume. Liver Transpl 8 1109-1113.
67. C Moreno Sanz, C Jiminez Romero, E Moreno Gonzalez, et al. (1999) Primary dysfunction after liver transplantation. Is it possible to predict this complication? Rev Esp Enferm Dig 91 401-419.
68. J Briceno, G Solorzano and C Pera (2000) A proposal for scoring marginal liver grafts. Transpl Int 13(Suppl 1), S249-S252.
69. M Heise, U Settmacher, R Pfitzmann, et al. (2003) A survival-based scoring-system for initial graft function following orthotopic liver transplantation. Transpl Int 16 794-800.
70. L Carrasco, F Sanchez-Bueno, J Sola, et al. (1998) Use of bile cytology for early diagnosis of complications in orthotopic liver transplantation. Cytopathology 9 406-414.
71. XH Fan, T Asahara, H Ohdan, et al. (2000) Nondestructive and real-time evaluation of liver viability in brain dead donor for liver transplantation using near-infrared spectroscopy. Transpl Int 13(Suppl 1), S272-S277.
72. L Gao, I Ramzan and B Baker (2002) Rocuronium plasma concentrations during three phases of liver transplantation: Relationship with early postoperative graft liver function. Br J Anaesth 88 764-770.
73. KJ Oldhafer, A Bornscheuer, NR Fruhauf, et al. (1999) Rescue hepatectomy for initial graft non-function after liver transplantation. Transplantation 67 1024-1028.
74. A Steib, G Freys, F Collin, et al. (1998) Does N-acetylcysteine improve hemodynamics and graft function in liver transplantation? Liver Transpl Surg 4 152-157.
75. JC Thies, J Teklote, U Clauer, et al. (1998) The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation. Transpl Int 11(Suppl 1), S390-S392.
76. KS Henley, MR Lucey, DP Normolle, et al. (1995) A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation. Hepatology 21 366-372.
77. D Skerrett, E Mor, S Curtiss and K Mohandas (1996) Plasmapheresis in primary dysfunction of hepatic transplants. J Clin Apheresis 11 10-13.
78. AA Demetriou, RS Brown Jr, RW Busuttil, et al. (2004) Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 239 660-667. discussion 667–670
79. F Amersi, DG Farmer, GD Shaw, et al. (2002) P-selectin glycoprotein ligand-1 (rPSGL-Ig)-mediated blockade of CD62 selectin molecules protects rat steatotic liver grafts from ischemia/reperfusion injury. Am J Transplant 2 600-608.